Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip

Journey Medical Corporation (NASDAQ: DERM) Listen to this Section


$4.46
-0.1000 ( -2.19% ) 59.8K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open


$4.46

Previous close


$4.56

Volume


59.8K

Market cap


$91.82M

Day range


$4.39 - $4.96

52 week range


$1.78 - $8.11

Insider Ownership Transactions

Total Amount Purchased: -92,291.00 | $ -411,617.86

Date Type Amount Purchased Purchaser
2024-08-01 Sale -9324.00 Benesch Joseph
2024-07-23 Sale -4055.00 Benesch Joseph
2024-07-23 Sale -30000.00 Pearce Michael Cooper
2024-07-10 Sale -9728.00 Smith Justin Adam
2024-07-10 Sale -9728.00 ROSENWALD LINDSAY A MD
2024-07-10 Sale -9728.00 Toledano Miranda Jayne
2024-07-10 Sale -9728.00 Herskowitz Neil
2024-05-31 Sale -50000.00 Fortress Biotech, Inc.
2024-03-27 Buy 10000.00 ROSENWALD LINDSAY A MD
2024-03-25 Buy 30000.00 Smith Justin Adam

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 87 Aug 13, 2024
8-k 8K-related 15 Aug 12, 2024
4 Insider transactions 1 Aug 01, 2024
4 Insider transactions 1 Jul 23, 2024
4 Insider transactions 1 Jul 23, 2024
3 Insider transactions 2 Jul 19, 2024
8-k 8K-related 13 Jul 12, 2024
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.